TECXTectonic Therapeutic, Inc.

$635M

Q1 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$291,000

Operating Income

-$27M

Net Income

-$27M

EPS (Diluted)

$-7.76

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$27M

Free Cash Flow

-$27M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$246M

Total Liabilities

$13M

Stockholders' Equity

$233M

Cash & Equivalents

$233M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$291,000	-$283,000	-2.8%
Operating Income	-$27M	-$27M	-1.1%
Net Income	-$27M	-$26M	-3.6%

TECX Q1 2021 Earnings — Tectonic Therapeutic, Inc. Revenue & Financial Results | Market Cap Arena